SERA PROGNOSTICS, INC.

(SERA)
  Rapporto
Tempo differito Nasdaq  -  22:00 11/08/2022
2.600 USD   +2.77%
10/08Sera Prognostics, Inc. riporta i risultati dei guadagni per il secondo trimestre e i sei mesi conclusi il 30 giugno 2022
CI
10/08Earnings Flash (SERA) SERA PROGNOSTICS registra un ricavo nel secondo trimestre di 78.000 dollari, rispetto a una stima della strada di 89.000 dollari.
MT
29/06Sera Prognostics nomina Jane Barlow nel Comitato di nomina e governance
CI
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietÓFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su SERA PROGNOSTICS, INC.
10/08SERA PROGNOSTICS: REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS - Form 8-K
10/08SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
10/08Sera Prognostics, Inc. Reports Earnings Results for the Second Quarter and Six Months E..
10/08Earnings Flash (SERA) SERA PROGNOSTICS Posts Q2 Revenue $78,000, vs. Street Est of $89,..
10/08Sera prognostics reports second quarter 2022 financial results
28/07Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 20..
29/06Sera Prognostics Appoints Jane Barlow to Nominating and Governance Committee
29/06SERA PROGNOSTICS, INC. Change in Directors or Principal Officers (form 8-K/A)
29/06Sera Prognostics Appoints Zhenya Lindgardt to the Compensation Committee of the Board
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2500 Growth Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2000 Growth Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2500 Value Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2000 Dynamic Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2000 Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2500 Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 2000 Value Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell Small Cap Comp Value Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell Small Cap Comp Growth Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000 Growth Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000E Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000E Growth Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000 Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell Small Cap Completeness Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000 Value Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell 3000E Value Index
24/06SERA PROGNOSTICS, INC.(NASDAQGM: SERA) dropped from Russell Microcap Growth Index
06/06SERA PROGNOSTICS, INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
06/06SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE
20/05Sera Prognostics, Inc. Announces Publication of Data Demonstrating Improved Performance..
19/05Sera prognostics announces publication of data demonstrating improved performance of it..
18/05Sera prognostics presents data demonstrating the health and economic benefit of pretrm«..
10/05Earnings Flash (SERA) SERA PROGNOSTICS Reports Q1 Revenue $38,000
10/05SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
10/05Sera Prognostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
10/05Sera prognostics reports first quarter 2022 financial results
05/05Sera prognostics and newborn foundation partner to reduce risks associated with preterm..
02/05Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 202..
12/04SERA PROGNOSTICS, INC.: Change in Directors or Principal Officers, Financial Statements a..
12/04Sera Prognostics, Inc Appoints Jane F. Barlow as Director to the Board to Serve as Clas..
29/03SERA PROGNOSTICS: REPORTS FOURTH QUARTER 2021 FINANCIAL RESULTS - Form 8-K
29/03Sera Prognostics Q4 Loss Narrows, Revenue Surges
29/03SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
29/03Sera Prognostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 20..
29/03Sera Prognostics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 3..
29/03Earnings Flash (SERA) SERA PROGNOSTICS Reports Q4 Revenue $26,000
29/03Sera prognostics reports fourth quarter 2021 financial results
18/03Sera Prognostics Reports Preeclampsia Predictability Data; Share Rise Midday
18/03Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Prote..
18/03Sera Prognostics Inc. Presents Data Demonstrating Prediction of Preeclampsia Utilizing ..
18/03Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Yea..
03/03Sera prognostics to present at upcoming march investor conferences
17/02Sera prognostics presentation rescheduled for citi 2022 healthcare conference
07/02Sera prognostics to present at upcoming february investor conferences
01/02Sera prognostics announces new agreement with multiplan, expanding patient access to th..
10/01Certain Warrants of Sera Prognostics, Inc. are subject to a Lock-Up Agreement Ending on..
10/01Certain Stock Options of Sera Prognostics, Inc. are subject to a Lock-Up Agreement End..
10/01Certain Class A Common Stock of Sera Prognostics, Inc. are subject to a Lock-Up Agreeme..
10/01Certain Class B Common Stock of Sera Prognostics, Inc. are subject to a Lock-Up Agreeme..
2021SERA PROGNOSTICS, INC.(NASDAQGM: SERA) added to NASDAQ Biotechnology Index
2021Sera Prognostics to Join Nasdaq Biotechnology Index
2021Sera prognostics added to nasdaq biotechnology index
2021Sera Prognostics Inc. Announces Pricing for PreTRM? Test, the Only Broadly Validated Bl..
2021Sera Prognostics Says Study Confirms Performance of Its Biomarkers to Address Preterm B..
2021Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/S..
2021SERA PROGNOSTICS, INC.: Change in Directors or Principal Officers (form 8-K)
2021Sera Prognostics, Inc. Appoints Sandra A. J. Lawrence to Board of Directors
2021SERA PROGNOSTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS - Form 8-K
2021SERA PROGNOSTICS, INC. Management's Discussion and Analysis of Financial Condition and..
2021Earnings Flash (SERA) SERA PROGNOSTICS Posts Q3 Revenue $23,000
2021Sera Prognostics Reports Third Quarter 2021 Financial Results
2021Sera Prognostics, Inc. Announces Unaudited Earnings Results for the third Quarter and n..
2021SERA PROGNOSTICS, INC.: Change in Directors or Principal Officers, Financial Statements a..
2021Sera Prognostics Announces The Appointment Of Zhenya Lindgardt To The Board
2021Sera Prognostics Inc. Announces the Appointment of Zhenya Lindgardt to the Board
2021Sera Prognostics Announces Publication of the Clinical Validation of PreTRM« Threshold ..
1  2Succ.
Prossimo evento su SERA PROGNOSTICS, INC.